This launch of Epinephrine Injection multiple-dose Vial is eligible for 180 days of CGT exclusivity under section 505(j)(5)(B)(v) of the FD&C Act.
Innovative chronic pain treatment receives IP protection in India's $55 billion pharmaceutical market
The launch of Chlorpromazine Hydrochloride for Injection is the latest in a series of recent product launches from Piramal Critical Care
This is the second Ready-To-Use Infusion bag (RTU Bags) ANDA drug product approved for Caplin Steriles
This product is indicated in coagulation disorders caused by vitamin K deficiency or interference with vitamin K activity.
Bumetanide Injection USP (RLD Bumex) had an estimated annual sale of USD 20 million in the US
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
Bumetanide Injection USP (RLD Bumex) had estimated annual sales of USD 20 million in the U.S.
ForDoz Pharma Corporation, USA (ForDoz) received an approval for its ANDA from the USFDA
Bortezomib Injection is approved for subcutaneous or intravenous use. It is available as a single dose vial of 3.5 mg/1.4 mL (2.5 mg/mL)
Subscribe To Our Newsletter & Stay Updated
